Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aggressive Pituitary Tumors and Pituitary Carcinomas: From Pathology to Treatment
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 108, Issue 7, Pages 1585-1601
Publisher
The Endocrine Society
Online
2023-03-01
DOI
10.1210/clinem/dgad098
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Rare Case of Pituitary Carcinoma With Bone Metastases
- (2022) Nuh Filizoglu et al. CLINICAL NUCLEAR MEDICINE
- The Genomic Landscape of Corticotroph Tumors: From Silent Adenomas to ACTH-Secreting Carcinomas
- (2022) Sergio Andonegui-Elguera et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- p53 null phenotype is a “positive result” in urothelial carcinoma in situ
- (2022) Ankur R. Sangoi et al. MODERN PATHOLOGY
- Complete Response of a Patient With a Mismatch Repair Deficient Aggressive Pituitary Adenoma to Immune Checkpoint Inhibitor Therapy: A Case Report
- (2022) Sanjit Shah et al. NEUROSURGERY
- Temozolomide and Capecitabine Treatment for an Aggressive Somatotroph Pituitary Tumor: A Case Report and Literature Review
- (2022) Atsushi Ishida et al. Frontiers in Oncology
- Improved pasireotide response in USP8 mutant corticotroph tumours in vitro
- (2022) Adriana Albani et al. ENDOCRINE-RELATED CANCER
- Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemia
- (2022) Megan J Fitzpatrick et al. HISTOPATHOLOGY
- Epigenomic and somatic mutations of pituitary tumors with clinical and pathological correlations in 111 patients
- (2022) Federica Guaraldi et al. CLINICAL ENDOCRINOLOGY
- Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study
- (2022) Mirela Diana Ilie et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Aggressive pituitary tumours and carcinomas, characteristics and management of 171 patients
- (2022) Pia Burman et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome
- (2022) Luis Gustavo Perez-Rivas et al. Acta Neuropathologica Communications
- Immunotherapy for Aggressive and Metastatic Pituitary Neuroendocrine Tumors (PitNETs): State-of-the Art
- (2022) Tiziana Feola et al. Cancers
- Corticotroph Tumor Progression after Bilateral Adrenalectomy (Nelson’s syndrome): Systematic Review and Expert Consensus Recommendations
- (2021) Martin Reincke et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- 68Ga-DOTATATE PET/CT in Pituitary Carcinoma
- (2021) Gursan Kaya et al. CLINICAL NUCLEAR MEDICINE
- Pituitary metastases from neuroendocrine neoplasms: case report and narrative review
- (2021) Alberto Ragni et al. Pituitary
- Two Pituitary Neuroendocrine Tumors (PitNETs) with Very High Proliferation and TP53 Mutation — High-Grade PitNET or PitNEC?
- (2021) Wolfgang Saeger et al. ENDOCRINE PATHOLOGY
- Growth hormone secreting pituitary carcinomas: Case report and review of literature
- (2021) Shivani Vekaria et al. GROWTH HORMONE & IGF RESEARCH
- Combination strategies to maximize the benefits of cancer immunotherapy
- (2021) Shaoming Zhu et al. Journal of Hematology & Oncology
- Efficacy of temozolomide combined with capecitabine (CAPTEM) on refractory prolactinomas as assessed using an ex vivo 3D spheroid assay
- (2021) Atsushi Ishida et al. Pituitary
- Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2020) M. Pavel et al. ANNALS OF ONCOLOGY
- Temozolomide therapy for aggressive pituitary tumours – current understanding and future perspectives
- (2020) Pia Burman et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- The epidemiology of aggressive pituitary tumors (and its challenges)
- (2020) Olaf M. Dekkers et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Somatic SF3B1 hotspot mutation in prolactinomas
- (2020) Chuzhong Li et al. Nature Communications
- Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas
- (2020) Giuseppe Minniti et al. JOURNAL OF NEURO-ONCOLOGY
- Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician’s questions
- (2020) Jacqueline Trouillas et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature
- (2020) Camille Duhamel et al. Journal of Personalized Medicine
- Effects of CAPTEM (Capecitabine and Temozolomide) on a Corticotroph Carcinoma and an Aggressive Corticotroph Tumor
- (2020) Tae Nakano-Tateno et al. ENDOCRINE PATHOLOGY
- Immune Checkpoint Inhibitor Therapy for ACTH-Secreting Pituitary Carcinoma: a new emerging treatment?
- (2020) Bastiaan Sol et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Bevacizumab in Aggressive Pituitary Adenomas – Experience with 3 Patients
- (2020) Katharina Osterhage et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors
- (2020) Andrew V Uzilov et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy
- (2020) Lydia S. Lamb et al. Frontiers in Endocrinology
- Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study
- (2020) Nazanin Majd et al. Journal for ImmunoTherapy of Cancer
- Effect of Everolimus in Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas
- (2019) Dongyun Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types
- (2019) Robert M. Samstein et al. NATURE GENETICS
- Apatinib (YN968D1) and temozolomide in recurrent invasive pituitary adenoma: case report and literature review
- (2019) Yong Wang et al. World Neurosurgery
- Pituitary Metastases: a Nationwide Study on Current Characteristics with Special Reference to Breast Cancer
- (2019) Fredrika Schill et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors
- (2019) Omalkhaire M. Alshaikh et al. ENDOCRINE PATHOLOGY
- Long-term cognitive dysfunction after radiation therapy for primary brain tumors
- (2019) Lene Haldbo-Classen et al. ACTA ONCOLOGICA
- A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial
- (2019) Grainne M O’Kane et al. BRITISH JOURNAL OF CANCER
- Use of radiotherapy after pituitary surgery for non-functioning pituitary adenomas
- (2019) Philippe Chanson et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
- (2019) Filipe Martins et al. Nature Reviews Clinical Oncology
- Pathology of pituitary neuroendocrine tumours: present status, modern diagnostic approach, controversies and future perspectives from a neuropathological and clinical standpoint
- (2019) Emilija Manojlovic‐Gacic et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience
- (2019) G Giuffrida et al. Endocrine Connections
- Radiation doses to brain substructures associated with cognition in radiotherapy of pediatric brain tumors
- (2019) Laura Toussaint et al. ACTA ONCOLOGICA
- Treatment and long-term outcomes in pituitary carcinoma: a cohort study
- (2019) Fernando Santos-Pinheiro et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Driver mutations in USP8 wild-type Cushing’s disease
- (2019) Silviu Sbiera et al. NEURO-ONCOLOGY
- How and when to use temozolomide to treat aggressive pituitary tumours
- (2019) Ben C Whitelaw ENDOCRINE-RELATED CANCER
- Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab
- (2019) Mario Caccese et al. ANTI-CANCER DRUGS
- An aggressive functioning pituitary adenoma treated with peptide receptor radionuclide therapy
- (2019) Majid Assadi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pangenomic Classification of Pituitary Neuroendocrine Tumors
- (2019) Mario Neou et al. CANCER CELL
- Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
- (2018) Ann McCormack et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Reduced Expression of Mismatch Repair Genes MSH6/MSH2 Directly Promotes Pituitary Tumor Growth via the ATR–Chk1 Pathway
- (2018) Shinsuke Uraki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- CLINICAL AND PATHOLOGICAL ASPECTS OF SILENT PITUITARY ADENOMAS
- (2018) Juliana Drummond et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Atypical pituitary adenoma: a clinicopathologic case series
- (2018) Martin J. Rutkowski et al. JOURNAL OF NEUROSURGERY
- Malignant transformation in non-functioning pituitary adenomas (pituitary carcinoma)
- (2018) Nèle Lenders et al. Pituitary
- Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review
- (2018) Frederick Yoo et al. Pituitary
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Early recognition and initiation of temozolomide chemotherapy for refractory, invasive pituitary macroprolactinoma with long-term sustained remission: a case report
- (2018) Garni Barkhoudarian et al. World Neurosurgery
- Marked response of a hypermutated adrenocorticotropic hormone-secreting pituitary carcinoma to ipilimumab and nivolumab
- (2018) Andrew L Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Large genomic aberrations in corticotropinomas are associated with greater aggressiveness
- (2018) Christina Tatsi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Identification of Novel Genes Involved in the Pathogenesis of an ACTH-Secreting Pituitary Carcinoma: A Case Report and Literature Review
- (2018) Fuyou Guo et al. Frontiers in Oncology
- European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas
- (2017) Gerald Raverot et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Diagnosis and Treatment of Pituitary Adenomas
- (2017) Mark E. Molitch JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Outcome of Nonfunctioning Pituitary Adenomas That Regrow After Primary Treatment: A Study From Two Large UK Centers
- (2017) Metaxia Tampourlou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Significant response of pituitary carcinoma to carboplatin, leucovorin and fluorouracil chemotherapy: a pediatric case report and review of the literature
- (2017) Mohamed S. AbdelBaki et al. JOURNAL OF NEURO-ONCOLOGY
- Ischemic stroke after radiation therapy for pituitary adenomas: a systematic review
- (2017) A. van Westrhenen et al. JOURNAL OF NEURO-ONCOLOGY
- Progressive visual disturbance and enlarging prolactinoma caused by melanoma metastasis
- (2017) Chuanwei Yang et al. MEDICINE
- Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
- (2017) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors of silent corticotroph adenoma recurrence; a large retrospective single center study and systematic literature review
- (2017) Fabienne Langlois et al. Pituitary
- Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
- (2017) Abir Salwa Ali et al. PLoS One
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
- (2017) Diego Chowell et al. SCIENCE
- Aggressive Pituitary Adenomas: The Dark Side of the Moon
- (2017) Stefano M. Priola et al. World Neurosurgery
- Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle
- (2016) Bernhard Nilica et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Growth hormone–secreting macroadenoma of the pituitary gland successfully treated with the radiolabeled somatostatin analog 90Y-DOTATATE: case report
- (2016) Joanna Waligórska-Stachura et al. JOURNAL OF NEUROSURGERY
- Is there a role for early chemotherapy in the management of pituitary adenomas?
- (2016) Andrew L. Lin et al. NEURO-ONCOLOGY
- Recurrent gain-of-function USP8 mutations in Cushing's disease
- (2015) Zeng-Yi Ma et al. CELL RESEARCH
- The Use of 68Ga DOTATATE PET/CT for Diagnostic Assessment and Monitoring of 177Lu DOTATATE Therapy in Pituitary Carcinoma
- (2015) Fuad Novruzov et al. CLINICAL NUCLEAR MEDICINE
- The Complementary Role of Transcription Factors in the Accurate Diagnosis of Clinically Nonfunctioning Pituitary Adenomas
- (2015) Hiroshi Nishioka et al. ENDOCRINE PATHOLOGY
- ErbB Receptor-Driven Prolactinomas Respond to Targeted Lapatinib Treatment in Female Transgenic Mice
- (2015) Xiaohai Liu et al. ENDOCRINOLOGY
- The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease
- (2015) K. Hayashi et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The epidemiology of pituitary adenomas in Iceland, 1955–2012: a nationwide population-based study
- (2015) Tomas Thor Agustsson et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide
- (2015) Daniel Bengtsson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Gene of the Ubiquitin-Specific Protease 8 Is Frequently Mutated in Adenomas Causing Cushing's Disease
- (2015) Luis G. Perez-Rivas et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas
- (2015) Marco Losa et al. JOURNAL OF NEURO-ONCOLOGY
- Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis
- (2015) Sabrina Chiloiro et al. NEUROENDOCRINOLOGY
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Temozolomide for aggressive ACTH pituitary tumors: failure of a second course of treatment
- (2015) Mariana Campderá et al. Pituitary
- Temozolomide retreatment in a recurrent prolactin-secreting pituitary adenoma: Hormonal and radiographic response
- (2015) RE Strowd et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Novel MSH6 Mutations in Treatment-Naive Glioblastoma and Anaplastic Oligodendroglioma Contribute to Temozolomide Resistance Independently of MGMT Promoter Methylation
- (2014) S. A. Nguyen et al. CLINICAL CANCER RESEARCH
- THERAPY OF ENDOCRINE DISEASE: The challenges in managing giant prolactinomas
- (2014) Dominique Maiter et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Mutations in the deubiquitinase gene USP8 cause Cushing's disease
- (2014) Martin Reincke et al. NATURE GENETICS
- A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up
- (2013) Jacqueline Trouillas et al. ACTA NEUROPATHOLOGICA
- DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
- (2013) Toshio Hirohata et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial
- (2013) Mark R. Gilbert et al. JOURNAL OF CLINICAL ONCOLOGY
- A Comprehensive Long-term Retrospective Analysis of Silent Corticotrophic Adenomas vs Hormone-Negative Adenomas
- (2013) Arman Jahangiri et al. NEUROSURGERY
- High Response Rates and Prolonged Survival in Patients With Corticotroph Pituitary Tumors and Refractory Cushing Disease From Capecitabine and Temozolomide (CAPTEM)
- (2013) Brad E. Zacharia et al. NEUROSURGERY
- Peptide receptor radionuclide therapy in a patient with disabling non-functioning pituitary adenoma
- (2013) Jan Komor et al. Pituitary
- Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation
- (2013) Jillian Maclean et al. Pituitary
- Clinical and biochemical characteristic features of metastatic cancer to the sella turcica: an analytical review
- (2013) Ribal Al-Aridi et al. Pituitary
- O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and low MGMT-encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy w
- (2012) Emmanuèle Lechapt-Zalcman et al. CANCER
- Temozolomide in the management of dopamine agonist-resistant prolactinomas
- (2012) B. C. Whitelaw et al. CLINICAL ENDOCRINOLOGY
- ACTH-secreting Crooke cell carcinoma of the pituitary
- (2012) Gábor L. Kovács et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
- (2011) Ann I. McCormack et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Pituitary Carcinoma with Malignant Growth from First Presentation and Fulminant Clinical Course—Case Report and Review of the Literature
- (2011) Katarzyna Dudziak et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas
- (2011) Fateme Salehi et al. JOURNAL OF NEURO-ONCOLOGY
- Immunohistochemical staining patterns of p53 can serve as a surrogate marker for TP53 mutations in ovarian carcinoma: an immunohistochemical and nucleotide sequencing analysis
- (2011) Anna Yemelyanova et al. MODERN PATHOLOGY
- A Mechanism of Acquiring Temozolomide Resistance During Transformation of Atypical Prolactinoma Into Prolactin-Producing Pituitary Carcinoma: Case Report
- (2011) Mineko Murakami et al. NEUROSURGERY
- New targeted therapies in pituitary carcinoma resistant to temozolomide
- (2011) Emmanuel Jouanneau et al. Pituitary
- Temozolomide responsiveness in aggressive corticotroph tumours: a case report and review of the literature
- (2011) A. K. Annamalai et al. Pituitary
- Anti-VEGF therapy in pituitary carcinoma
- (2011) Leon D. Ortiz et al. Pituitary
- Temozolomide: Mechanisms of Action, Repair and Resistance
- (2011) Jihong Zhang et al. Current Molecular Pharmacology
- Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
- (2010) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy
- (2009) C Hagen et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Radiosensitizing Effects of Temozolomide Observed in vivo only in a Subset of O6-Methylguanine-DNA Methyltransferase Methylated Glioblastoma Multiforme Xenografts
- (2009) Brett L. Carlson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Evolution of an Aggressive Prolactinoma into a Growth Hormone Secreting Pituitary Tumor Coincident with GNAS Gene Mutation
- (2009) Andrea G. Lania et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Possible role of a radiation-induced p53 mutation in a Nelson’s syndrome patient with a fatal outcome
- (2009) Emilia Modolo Pinto et al. Pituitary
- Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor
- (2009) Marie S. Thearle et al. Pituitary
- In vitro and In vivo Radiosensitization Induced by the DNA Methylating Agent Temozolomide
- (2008) W. J. Kil et al. CLINICAL CANCER RESEARCH
- P53gene mutation in an atypical corticotroph adenoma with Cushing's disease
- (2008) Sachiko-Tsukamoto Kawashima et al. CLINICAL ENDOCRINOLOGY
- Malignant pituitary corticotroph adenomas: report of two cases and a comprehensive review of the literature
- (2008) Agatha A. van der Klaauw et al. Pituitary
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started